A Pancreatic Cancer Organoid-in-Matrix Platform Shows Distinct Sensitivities to T Cell Killing

The study addresses the challenges of poor treatment responses in pancreatic ductal adenocarcinoma (PDAC) due to tumor heterogeneity and an immunosuppressive tumor microenvironment (TME). It introduces the InterOMaX model system, a 3D co-culture platform that mimics matrix-dependent cellular crosstalk to investigate T cell responses in PDAC. This system uses a customizable matrix and organoid-in-matrix positioning to co-culture PDAC cells with T cells and stromal cells. By detecting and analyzing PDAC cell populations with varying sensitivity to T cell killing, the platform enables identification and validation of gene candidates for T cell resistance, advancing the understanding of cancer cell-intrinsic resistance phenotypes in PDAC.

Keywords: Pancreatic cancer organoid, T-cell killing, pancreatic ductal adenocarcinoma, tumor microenvironment

Subscribe to the latest updates in the newsletter

Share your disease area, therapeutic candidate and research objectives.

Related Solutions

Organoid Service
Research Service
Technical Service

ODISEI CNS - Human brain & retinal organoid
solutions for translational CNS discovery.

Please provide the information below, and our team will contact you shortly with brochure and relevant case studies.

Thank you for your submission.

Our team has received your request and will get back to you shortly.
If you do not receive our confirmation email, kindly check your spam or junk folder.